1. Results of the first planned analysis of theTEAM(tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal…

Articles www.thelancet.com Published online July 24, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61074-1 1 Aromatase inhibitors versus tamoxifen in early breast cancer:…

Slide 1 1 Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal…

Slide 1 1 Study Of Letrozole Extension IBCSG 35-07/BIG 1-07 S LE Slide 2 2 A phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following…

San Antonio Breast Cancer Symposium 2010 San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine Objectives Adjuvant tamoxifen duration (S1-2)…

A Report from SABCS Up-to-Date Review of the Treatment of Early Breast Cancer Maura N. Dickler, MD Assistant Attending Physician Breast Cancer Medicine Service Memorial Sloan-Kettering…

PowerPoint Presentation Screening Mammography Value vs. Jeopardy Archie Bleyer, MD [email protected] Department of Radiation Medicine Knight Cancer Institute…

San Antonio Breast Cancer Symposium 2010 San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine Objectives Adjuvant tamoxifen duration (S1-2)…

Endocrine therapy in breast cancer Endocrine therapy in breast cancer Dr.Mina Tajvidi Radiation oncologist Endocrine therapy in breast cancer Endocrine therapy for hormone…

www.oncologytribune.com Extending tamoxifen use improves breast cancer outcomes CASE STUDY NEWS 2012 in retrospective: Report highlights advances in oncology CONFERENCE Ponatinib…